Paul Purdy Hasmukh Chudgar Binish Chudgar Nimish Chudgar Urmish Chudgar Rakesh Bamzai Abhimanyu Ojha Dr
Summary TGAs new harmonized warnings reflect a precautionary, evidence-based approach
The clinical concern is not about drug testing but about gastroparesis risk: semaglutide slows gastric emptying, which can increase aspiration risk under general anesthesia if fasting protocols are not appropriately extended
In the third sensitivity analysis, excluding patients using other types of glucagon-like peptide-1 receptor agonists, the use of once-weekly semaglutide still independently predicted a higher risk of upcoming NAION (multivariable adjusted HR 234, 95% CI 154 357), compared to non-semaglutide users in a multivariable model adjusted as in the first sensitivity analysis
One study led by researchers at University Hospitals in Cleveland used records collected by the TriNetX database, which includes millions of patient records from 80 contributing heath care organizations
Research Overview: GLP-1 Receptor Agonism and Metabolic Flux The primary scientific value of Semaglutide 3mg is its ability to evade rapid clearance in laboratory models
